Gadgeel, Shirish
Shaw, Alice T
Barlesi, Fabrice
Crinò, Lucio
Yang, James Chih-Hsin
Dingemans, Anne-Marie C
Kim, Dong-Wan
de Marinis, Filippo
Schulz, Mathias
Liu, Shiyao
Gupta, Ravindra
Kotb, Ahmed
Ou, Sai-Hong Ignatius
Article History
Received: 17 July 2017
Revised: 2 October 2017
Accepted: 11 October 2017
First Online: 16 November 2017
Competing interests
: SG has participated in advisory boards for Genentech/Roche, Ariad, Pfizer, and Bristol-Myers Squibb, and received honoraria for non-branded presentations for Genentech/Roche; ATS has participated in advisory boards for Pfizer, Novartis, Roche/Genentech, Ariad, Blueprint Medicines, Loxo, and EMD Serono, and received honoraria for non-branded presentations for Pfizer, Novartis, Genentech/Roche, Ignyta, Taiho and Foundation Medicine; FB has participated in advisory boards for Genentech/Roche, Novartis, and Pfizer, and received honoraria for non-branded presentations for Genentech/Roche and Novartis; LC has received honoraria from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, and Pfizer; JC-HY has participated in compensated advisory boards for Boehringer Ingelheim, Eli Lilly, Bayer, Roche/Genentech/Chugai, Astellas, MSD, Merck Serono, Pfizer, Novartis, Clovis Oncology, Celgene, Merrimack, Yuhan Pharmaceuticals, Bristol-Myers Squibb, and Ono Pharmaceutical, and in an uncompensated advisory board for AstraZeneca; A-MCD has participated in advisory boards for Genentech/Roche, Pfizer, Eli Lilly, Clovis, and MSD, and received honoraria for non-branded presentations for Genentech/Roche and AstraZeneca (paid to her institute); D-WK has no conflict of interest to disclose; FdM has participated in advisory boards for Genentech/Roche, Boehringer, and Novartis, and received honoraria for non-branded presentations from Genentech/Roche, AstraZeneca, Bristol-Mayer Squibb, and Pfizer; MS is an employee of Genentech and owns Roche stocks; SL and RG are employees of Genentech and own shares in the company; AK is an employee of F. Hoffmann-La Roche Ltd and owns shares in the company; S-HIO has acted in a consulting or advisory role to ARIAD, AstraZeneca, Boehringer Ingelheim, Novartis, and Roche, and participated in Speaker Bureaus for AstraZeneca, Boehringer Ingelheim, and Roche/Genentech.